Everest Medicines partners with Shanghai Pharma Subsidiary to accelerate the commercialization of XERAVA in Mainland China
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
The blood test market worldwide is today around $75-80 billion
Study efficacy measures will include the expression of dystrophin protein and motor function.
The new team members, Solenn Percelay and Noémie Spinelli, will support the organization’s commitment to excellence in humanized mouse model care and use
NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Bourgoin early development hub broadens offerings for oral solid dose formulations
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Subscribe To Our Newsletter & Stay Updated